Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ACCURAY INC chart...

About the Company

Accuray is a radiation therapy company that develops, manufactures, and sells radiation therapy systems to deliver treatments including stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). It is the developer of innovative technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, the latest generation TomoTherapy platform. The company is headquartered in Sunnyvale, CA, the United States. The platforms are installed in leading healthcare centres in approximately 50 countries globally.

Exchange

Nasdaq

$447M

Total Revenue

1K

Employees

$215M

Market Capitalization

-17.69

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ARAY News

Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024

6h ago, source:

Accuray Incorporated (NASDAQ: ARAY) announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest ...

Accuray Down on CyberKnife and Radixact at Scotland Meeting

3h ago, source: InvestingChannel on MSN

Accuray Incorporated (NASDAQ: ARAY) shares lost ground Thursday, on word that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO ...

Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp

18d ago, source: Seeking Alpha

Despite management guidance that points to significant revenue acceleration in the next two quarters, Accuray shares have languished. Market skepticism can be tied in part to the company's track ...

Accuray Reports Positive Results For CyberKnife System In High-risk, Recurrent Prostate Cancer

1mon ago, source: Business Insider

(RTTNews) - Radiation therapy company, Accuray Inc. (ARAY), Tuesday announced that the latest data from two clinical studies supported the use of CyberKnife system for the treatment of patients ...

Accuray Inc.

28d ago, source: Wall Street Journal

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland

7d ago, source: Stockhouse

MADISON, Wis., April 18, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of its commitment to advancing patient care the company has opened a new training center ...

Accuray Inc's CyberKnife System shows promise in prostate cancer treatment

1mon ago, source: Investing

MADISON, Wis. - Accuray (NASDAQ:ARAY) Incorporated (NASDAQ: ARAY) has presented new data at the 2024 Radiosurgery Society Meeting in Chicago, indicating that the CyberKnife System could be a ...

Accuray Inc's CyberKnife System shows promise in prostate cancer treatment

1mon ago, source: Investing

MADISON, Wis. - Accuray (NASDAQ:ARAY) Incorporated (NASDAQ: ARAY) has presented new data at the 2024 Radiosurgery Society Meeting in Chicago, indicating that the CyberKnife System could be a viable ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...